Veno Occlusive Disease, Hepatic Withdrawn Phase 4 Trials for Sodium 1,2-Dipalmitoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (DB14105)

Also known as: Hepatic Veno-Occlusive Disease / Venoocclusive liver disease / Veno-occlusive disease of liver / Veno-occlusive liver disease / Veno-occlusive disease of the liver (disorder) / Venoocclusive syndrome of the liver / Sinusoidal obstruction syndrome

IndicationStatusPhase
DBCOND0105973 (Veno Occlusive Disease, Hepatic)Withdrawn4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03963999Validating Ultrasound Biomarkers for Hepatic Sinusoidal Obstruction Syndrome in Pediatric Hematopoietic Cell Transplant PatientsDiagnostic